ImmunityBio, Inc.IBRXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-87.2%
5Y CAGR-69.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-87.2%/yr
vs +9.0%/yr prior
5Y CAGR
-69.6%/yr
Recent deceleration
Acceleration
-96.2pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 23.05 | -84.2% |
| 2024 | 145.53 | -97.0% |
| 2023 | 4846.66 | -56.0% |
| 2022 | 11027.60 | +263.8% |
| 2021 | 3031.16 | -65.7% |
| 2020 | 8840.35 | -73.8% |
| 2019 | 33757.90 | +332.2% |
| 2018 | 7811.52 | -74.9% |
| 2017 | 31175.41 | -27.0% |
| 2016 | 42714.87 | - |